dacarbazine,doxorubicin,brentuximab vedotin,vinblastine,bleomycin,vincristine
seagen
[]
hd21
- non-inferiority demonstrated w hr 0.63 (may show superiority with longer followup) - os unchanged (classification of deaths seems problematic tho doesn t change result) very impressive regimen
#17icml 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem